Quick map
- Mono GLP-1 (e.g. semaglutide literature) — incretin + satiety + delayed emptying.
- Amylin analogues — amylin receptor; often studied with incretins, not as GLP-1 clones.
- Fragments such as AOD-9604 — historical GH-fragment lipolysis research; different biology again.
- Do not treat all “fat loss peptides” as interchangeable in experimental design.
- Do not import clinical titration schedules into laboratory research notebooks as if they were SOPs for research chemicals.